Company Overview

Update
Status:
Acquired by Abbott Labs
Headquarters:
Webster, TX
Funding:
$59.70M
Categories:
Biotechnology

IDEV Technologies is a medical device company focused on the development of products for endovascular and interventional applications.

Description

Update

IDEV Technologies is an emerging growth medical device company focused on the development of products for endovascular and interventional applications. Currently, IDEV markets SUPERA, a novel self-expanding nitinol stent. Using a patented interwoven design, SUPERA offers improved flexibility, radial strength, and kink and crush resistance compared to other marketed stents. SUPERA is currently approved for use in the treatment of biliary strictures in the US. IDEV is currently enrolling patients in the SUPERB IDE trial to study SUPERA's safety and efficacy when used in the superficial femoral artery (SFA).

Current Team (2)

Update

Board Members and Advisors (1)

Update

Funding Rounds (3) - $59.70M

Update

Investors (5)

Update
  • C5bdefc91fb80832e5fea190af9667c6

    Piper Jaffray Private Capital Group

    Piper Jaffray has been evolving as a leading financial services company. They pride themselves on..
  • B1a7eb07eaf6caf704eaf803654c54fa

    PTV Sciences

    Healthcare Venture Capital
  • Da17a4c082b68ed11bc45376844c4e24

    Bay City Capital

    Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing..
  • F371822011988fb622b50fe82b8544b9

    Heron Capital

    Heron Capital is a venture capital fund dedicated to investing in mid and growth stage companies..
  • 714d48059d1af92414c60e2b764b83a3

    RiverVest

    Early-Stage Biotech Investment

Offices/Locations (1)

Update
  • Office

    253 Medical Center Blvd.

    Webster, TX 77598

    USA